Jim Simons Cidara Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,554,973 shares of CDTX stock, worth $28.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,554,973

Previous 1,802,173 41.77%

Holding current value

$28.6 Million

Previous $1.43 Million 64.29%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.64 - $0.92 $481,792 - $692,576	752,800 Added 41.77%	2,554,973 $2.35 Million
Q4 2023 Feb 13, 2024	BUY	$0.68 - $0.97 $137,700 - $196,425	202,500 Added 12.66%	1,802,173 $1.43 Million
Q3 2023 Nov 14, 2023	BUY	$0.77 - $1.16 $38,577 - $58,115	50,100 Added 3.23%	1,599,673 $1.51 Million
Q2 2023 Aug 11, 2023	BUY	$1.01 - $1.42 $295,728 - $415,776	292,800 Added 23.3%	1,549,573 $1.75 Million
Q1 2023 May 12, 2023	BUY	$0.75 - $1.98 $53,550 - $141,372	71,400 Added 6.02%	1,256,773 $1.6 Million

Q4 2022 Feb 13, 2023	SELL	$0.48 - $0.76 $51,792 - $82,004	-107,900 Reduced 8.34%	1,185,373 $896,000
Q3 2022 Nov 14, 2022	BUY	$0.45 - $0.81 $61,657 - $110,982	137,016 Added 11.85%	1,293,273 $812,000
Q2 2022 Aug 12, 2022	SELL	$0.43 - $0.91 $121,082 - $256,245	-281,588 Reduced 19.58%	1,156,257 $565,000
Q1 2022 May 13, 2022	BUY	$0.67 - $1.39 $15,803 - $32,787	23,588 Added 1.67%	1,437,845 $1.2 Million
Q4 2021 Feb 11, 2022	BUY	$1.18 - $2.18 $346,915 - $640,911	293,996 Added 26.24%	1,414,257 $1.8 Million
Q3 2021 Nov 12, 2021	BUY	$1.48 - $2.35 $109,457 - $173,801	73,958 Added 7.07%	1,120,261 $2.51 Million
Q2 2021 Aug 13, 2021	BUY	$1.87 - $2.7 $444,686 - $642,060	237,800 Added 29.41%	1,046,303 $2.11 Million
Q1 2021 May 13, 2021	SELL	$2.06 - $3.01 $1.55 Million - $2.26 Million	-751,151 Reduced 48.16%	808,503 $2.15 Million
Q4 2020 Feb 10, 2021	BUY	$1.99 - $3.25 $606,858 - $991,100	304,954 Added 24.3%	1,559,654 $3.12 Million
Q3 2020 Nov 13, 2020	BUY	$2.85 - $4.1 $299,711 - $431,164	105,162 Added 9.15%	1,254,700 $3.58 Million
Q2 2020 Aug 13, 2020	BUY	$2.39 - $4.0 $511,314 - $855,756	213,939 Added 22.87%	1,149,538 $4.24 Million
Q1 2020 May 14, 2020	BUY	$1.74 - $4.26 $243,497 - $596,148	139,941 Added 17.59%	935,599 $2.32 Million
Q4 2019 Feb 13, 2020	BUY	$1.77 - $3.84 $212,346 - $460,684	119,970 Added 17.76%	795,658 $3.06 Million
Q3 2019 Nov 13, 2019	BUY	$1.25 - $2.35 $81,182 - $152,623	64,946 Added 10.63%	675,688 $1.35 Million
Q2 2019 Aug 12, 2019	BUY	$1.49 - $2.94 $318,874 - $629,189	214,010 Added 53.94%	610,742 $1.03 Million
Q1 2019 May 14, 2019	BUY	$2.35 - $3.27 $188,545 - $262,358	80,232 Added 25.35%	396,732 $1.05 Million
Q4 2018 Feb 13, 2019	BUY	$2.1 - $4.5 $664,650 - $1.42 Million	316,500 New	316,500 $744,000

Others Institutions Holding CDTX

# of Institutions

Shares Held

22.2M

Call Options Held

2.7K

Put Options Held

100

View Full List

About Cidara Therapeutics, Inc.

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $786M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

More about CDTX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account